Skip to main content

Animations

MJFF Publications

3091 - 3100 of 9131 Results
Title
Year
  • Year
  • 2023
  • 2018
  • 2023
  • 2021
  • 2018
  • 2023
  • 2020
  • 2021
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: Multimodal assessment of mitochondrial function in Parkinson's disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad364
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington’s disease
    Journal Name: BMC Medical Research Methodology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12874-018-0592-9
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Letter in response to Cole-Hunter et al., 2023: What does “Parkinson’s disease mortality” mean?
    Journal Name: Environment International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.envint.2023.107852
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2021.102558
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons
    Journal Name: The American Journal of Human Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018
    Citation Count: 71
  • Summary Details
    OPEN
    Title: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy
    Journal Name: SLAS Discovery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.aaz9165
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Common and rare variants in HFE are not associated with Parkinson's disease in Europeans
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.019
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy
    Journal Name: ACS Pharmacology & Translational Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162
    Citation Count: 30
  • Summary Details
    OPEN
    Title: ThX – a next-generation probe for the early detection of amyloid aggregates
    Journal Name: Chemical Science
    Publisher: Royal Society of Chemistry (RSC)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1039/c9sc04730a
    Citation Count: 81
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.